businessfortnight

Classic Legends Private Limited (CLPL), subsidiary of Mahindra and Mahindra Ltd., will start production of JAWA motorcycles – which were discontinued in the mid-1990’s – in July, at their Pithampur facility in Madhya Pradesh. In 2016, Anand Mahindra, Chairman of the Mahindra Group, had struck a deal with the Czechoslovakia-based iconic motorcycle company, which will allow CLPL to launch and market bikes under the JAWA brand name in Indian and East Asian markets. With just a few days left for production to hit the floor, Anand Mahindra sent out a Tweet which contained a meme of a motorcyclist driving a bike in the rain, bearing the quote “Life isn’t about waiting for the storm to pass, it’s about learning to ride in the rain.” The bikes are expected to be modeled around the JAWA 250, and will compete directly with Royal Enfield. No details have been released regarding the specifications of the bike, however, it can be presumed that the retro look of the iconic bike would be kept intact

For Immediate Release Mumbai, 2018:  A brainchild of Dr. Atish Laddad, The Pediatric Network (TPN) is an alternative child health support program that aims to acquire a holistic healthcare and wellbeing for every child. Its chief objective has always been to bestow children across India with a healthy and sheltered lifestyle by making positive alterations and advancements in the treatment methods and functioning of paediatricians. Keeping this perspective in mind, TPN is all set to take its first steps towards embracing the path of digitalization by introducing Machine Learning a contemporary way to revolutionize the delivery procedure of medical prescriptions. This digital marvel is all set to change the traditional and mundane scenario typically witnessed in a medical clinic, wherein the patient enters the clinic’s reception to take an appointment and waits for hours until the examination to get a medical prescription.                                                                

Life insurance is a product that’s sold and not bought. At least that’s what the insurance industry believes and therefore banks on its army of agents to convince you to buy life insurance. For this, the agent gets a cut from the premium that you pay. So, every time you cut a premium cheque, the agent makes money too. In other words, agents are entitled to a commission not just on selling a policy, but also when you pay renewal premiums. Renewal commissions are given as an incentive to keep the agent’s skin in the game so that he remains motivated to service your policy. You would think that this steady pipeline of commission stops when the agent leaves you, right? Wrong. The agents can get commissions even after they stop servicing your insurance policy. Till 2015, this was the law, but the Insurance Laws Amendment Act, 2015, repealed the law and subsequently the decision moved to the board of insurance companies. Read on to understand the old rules and how they have changed now, and

Two wheelers are the most affordable and convenient form of personal transport. In a country like India, where the traffic congestion is increasing with each passing day, hence travelling in cars can be frustrating. Two wheelers are at an advantage as they can be maneuvered easily and can be parked even in cramped spaces. Which is why many individuals turn to two wheelers such as bikes and scooters for their daily commute. If you are planning to buy a two wheeler, you will be inundated by the numerous choices existing in the market today. Hence it is important to do a little research by yourself so that you make the right purchase decision. Here are some important pointers to keep in mind before buying a two wheeler in India: – Pick the Brand Carefully Buying a two wheeler is a long term investment, hence you need to make the decision carefully. It’s always a great idea to buy your vehicle for a well-established brand as quality is of utmost importance. Some of the top two wheeler man

In a bid to give a fresh identity to the 165-year-old Indian Railways, the Railway Board is all set to revamp the traditional dark blue colour coaches with a new colour scheme – beige and brown. To follow this through, close to 30,000 coaches of mail and express trains would be repainted in coordination with the National Institute of Fashion Technology (NIFT) and National Institute of Design (NID). The 16-coach Delhi-Pathankot Express will be the first train to flaunt the new look, and is expected to hit the tracks by June end. While interacting with IANS, a Railways official said, “A complete makeover of coaches was long overdue, and the new colour scheme was applied in trains after it was finally approved by the Railways Minister Piyush Goyal.” In order to provide a better travelling experience to the passengers, the Railways has been trying since the past few years, to enhance the overall look and feel of the trains. Few of the changes introduced include substitution of traditional

KTM 390 Adventure is all set to launch later this year. Pictures of the adventure bike have been leaked for months now. But Bajaj has finally confirmed about its arrival by March 2019 after its global debut at the EICMA show in November. According to a RushLane report, Amit Nandi, President (Pro-biking), Bajaj Auto Ltd, said KTM is a niche brand and it will enter the niche premium dual-sport segment with the 390 Adventure. He also said the bike was apt for Indian roads. The new bike will be modelled on the Duke 390 and will include many features in common with the 950 Adventure, the 1190 Adventure and the 1290 Super Adventure. Other features for the 390 Adventure include longer suspension, dual purpose tyres and a large fuel tank. The bike would also give more comfort over long distances because of its upright seat position. The bike would feature design specifications like a tall windshield, ergonomically designed rider and pillion rider seat, LED projector headlamps, underbody prote

Bengaluru:  Britain’s Indivior PLC fell by more than 20% on Friday after the US Food and Drug Administration (FDA) approved the first generic versions of Suboxone Film, an opioid addiction treatment that generates 80% of its revenue. Dr Reddy’s Laboratories received FDA approval for a copy-cat version of the treatment, which has been rapidly losing market share due to competition from generics. Mylan NV also received approval to market the substitute drug. Shares in Indivior, which was spun out from Reckitt Benckiser in 2014, were down 22.7% at 0925 GMT and the biggest loser on the FTSE midcap index. Dr Reddy’s said it would launch its therapeutic equivalent of Suboxone, which is a composition of buprenorphine and naloxone, at risk, with an approved risk evaluation and mitigation strategy (REMS) program. One analyst said the at-risk sudden launch was a surprise and could threaten Indivior’s 2018 guidance. A spokesman for Indivior said the company was preparing to release a statement.